BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25048745)

  • 1. Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical setting.
    Comas C; Echevarria M; Rodríguez MA; Prats P; Rodríguez I; Serra B
    J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1196-201. PubMed ID: 25048745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
    Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical implementation of non-invasive prenatal study for detecting aneuploidies by fetal DNA based on single nucleotide polymorphisms: two years in Mexico].
    Sánchez-Usabiaga RA; Aguinaga-Ríos M; Batista-Espinoza A; Hurtado-Amador R; Romero-Tovar S
    Ginecol Obstet Mex; 2015 Apr; 83(4):220-31. PubMed ID: 26727755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population.
    Fairbrother G; Johnson S; Musci TJ; Song K
    Prenat Diagn; 2013 Jun; 33(6):580-3. PubMed ID: 23494956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA.
    McKanna T; Ryan A; Krinshpun S; Kareht S; Marchand K; Grabarits C; Ali M; McElheny A; Gardiner K; LeChien K; Hsu M; Saltzman D; Stosic M; Martin K; Benn P
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):73-79. PubMed ID: 30014528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening.
    Petersen OB; Vogel I; Ekelund C; Hyett J; Tabor A; ;
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):265-71. PubMed ID: 24375770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.
    Quezada MS; Gil MM; Francisco C; Oròsz G; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):36-41. PubMed ID: 25251385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Performance of prenatal screening by non-invasive cell-free fetal DNA testing for women with various indications].
    Zhang B; Pan L; Wang H; Liu J; Lu B; Chen Y; Long W; Yu B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):51-55. PubMed ID: 29419860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].
    Hernández-Gómez M; Ramirez-Arroyo E; Meléndez-Hernández R; Garduño-Zaraza LM; Mayén-Molina DG
    Ginecol Obstet Mex; 2015 May; 83(5):277-88. PubMed ID: 26233973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.
    Friel LA; Czerwinski JL; Singletary CN
    Am J Perinatol; 2014 Oct; 31(9):759-64. PubMed ID: 24338115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary analysis of the cause for the failure of non-invasive prenatal testing using cell-free fetal DNA derived from peripheral maternal blood].
    Zhang B; Shen C; Wang H; Cai Z; Lu B; Zhang X; Yu B; Wang T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):329-333. PubMed ID: 29896725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.
    Conner P; Gustafsson S; Kublickas M
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):368-75. PubMed ID: 25581307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free DNA testing in the maternal blood in high-risk pregnancies after first-trimester combined screening.
    Persico N; Boito S; Ischia B; Cordisco A; De Robertis V; Fabietti I; Periti E; Volpe P; Fedele L; Rembouskos G
    Prenat Diagn; 2016 Mar; 36(3):232-6. PubMed ID: 26749576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.
    Li R; Wan J; Zhang Y; Fu F; Ou Y; Jing X; Li J; Li D; Liao C
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):53-7. PubMed ID: 26033469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chances and Challenges of New Genetic Screening Technologies (NIPT) in Prenatal Medicine from a Clinical Perspective: A Narrative Review.
    Bedei I; Wolter A; Weber A; Signore F; Axt-Fliedner R
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33805390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free DNA analysis for noninvasive examination of trisomy.
    Norton ME; Jacobsson B; Swamy GK; Laurent LC; Ranzini AC; Brar H; Tomlinson MW; Pereira L; Spitz JL; Hollemon D; Cuckle H; Musci TJ; Wapner RJ
    N Engl J Med; 2015 Apr; 372(17):1589-97. PubMed ID: 25830321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of noninvasive prenatal testing for common fetal aneuploidies in an early gestational window.
    Shi X; Zhang Z; Cram DS; Liu C
    Clin Chim Acta; 2015 Jan; 439():24-8. PubMed ID: 25286007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies.
    Bevilacqua E; Gil MM; Nicolaides KH; Ordoñez E; Cirigliano V; Dierickx H; Willems PJ; Jani JC
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):61-6. PubMed ID: 25297464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.